Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Shriners Hospitals for Children | OTHER |
| University of Nebraska | OTHER |
| University of Washington | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss, dental problems, pain and difficulty getting around. Before the genetic cause of OI was known, OI was classified into four types. Each type was based upon the symptoms and severity of OI. In most people with OI, the cause is a change in one of the genes that makes a protein called type 1 collagen. Some doctors now classify OI both on how severe it is as well as which gene is causing OI. When people classify OI this way, there are more than 10 types of OI. The current laboratory testing to determine OI subtype involves the collection of blood and/or skin cells.
Osteogenesis Imperfecta (OI) is a rare disorder that causes bones to break easily. People with OI may have broken bones with little or no trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. OI can range from very severe to very mild. Individuals with the most severe type of OI may die at birth. People with severe OI who survive may have bowed arms and legs, very short stature and be unable to walk. People with the mildest form of OI may only break bones occasionally and have normal height and lifespan. Breaks can occur in any bone, but are most common in the arms and legs. People with OI also often have problems with the spine. The spine problems include compression fractures and scoliosis (a curvature of the spine). DI is characterized by grey or brown teeth that may chip and wear down and break easily. In addition to weak teeth, the teeth in the upper jaw may not match up with the teeth in the lower jaw.
Before the genetic cause of OI was known, OI was classified into four types. Each type was based upon the symptoms and severity of OI. In most people with OI, the cause is a change in one of the genes that makes a protein called type 1 collagen. In the past decade, it was discovered that in about 5% of people with OI it is in another gene. Some doctors now classify OI both on how severe it is as well as which gene is causing OI. When people classify OI this way, there are more than 10 types of OI. The current laboratory testing to determine OI subtype involves the collection of blood and/or skin cells.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Individuals with OI | Individuals with OI with confirmed specific genetic mutations | ||
| Controls/Unaffected | Individuals who do not have OI and who are not related to an individual with OI |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| HP/LP Ratio | The endpoint will be to compare the HP/LP ratio in OI patients with collagen overmodification (dominant negative mutations in COL1A1, COL1A2, and biallelic mutations in CRTAP, LEPRE1, PPIB) to those without overmodification (FKBP10, SERPINH1, IFITM5, SERPINF1, WNT1, and haploinsufficient mutations in COL1A1 and COL1A2). | 5 Years |
| Measure | Description | Time Frame |
|---|---|---|
| HP/LP ratio | The endpoint would be the HP/LP ratio in those with dominant negative type I collagen mutations vs. those with mutations in P3H complex. | 5 Years |
Not provided
Inclusion Criteria:
Be enrolled in The Longitudinal Study of OI (NTC #02432625) and have one of the following genetic mutations:
If you are serving as a control, you must not be related to an individual with OI.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Individuals with OI
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Vernon Reid Sutton, M.D. | Baylor College of Medicine | Principal Investigator |
| Frank Rauch, M.D. | Shriners Hospital for Children | Principal Investigator |
| David Eyre, Ph.D. | University of Washington | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California Los Angeles | Los Angeles | California | 90095 | United States | ||
| University of Nebraska Medical Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010013 | Osteogenesis Imperfecta |
| ID | Term |
|---|---|
| D010009 | Osteochondrodysplasias |
| D001848 | Bone Diseases, Developmental |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Urine samples will be collected
| Omaha |
| Nebraska |
| 68198 |
| United States |
| Hospital for Special Surgery | New York | New York | 10021 | United States |
| Oregon Health Science University | Portland | Oregon | 97239 | United States |
| Baylor College of Medicine | Houston | Texas | 77030 | United States |
| Shriners Hospital for Children | Milwauke | Wisconsin | 53201 | United States |
| Shriners Hospital for Children | Montreal | Quebec | H3G 1A6 | Canada |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D003095 | Collagen Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |